Evidence map›Paper›PMID 27650551›Full record

ReviewPharmaceutical biology2017

The anti-inflammatory activity of licorice, a widely used Chinese herb.

Rui Yang, Bo-Chuan Yuan, Yong-Sheng Ma, Shan Zhou, Ying Liu

Open access · hybridAbstract readReview
In one paragraph

Review in Pharmaceutical biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 173 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
173citing papers in PubMed, 1 pooled it
18.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

173 citing papers in PubMed, 1 synthesis or guideline pooled it, 389 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Biology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Formulation and Biological Evaluation ofAntioxidants (Basel, Switzerland) · 2026
    Article
  14. International journal of medical sciences · 2026
    Article
  15. Liquiritin ameliorates atherosclerosis in ApoEIranian journal of basic medical sciences · 2026
    Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article

113 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Rui Yanga School of Chinese Pharmacy, Beijing University of Chinese Medicine , Beijing , China.
Bo-Chuan Yuana School of Chinese Pharmacy, Beijing University of Chinese Medicine , Beijing , China.
Yong-Sheng Maa School of Chinese Pharmacy, Beijing University of Chinese Medicine , Beijing , China.
Shan Zhoua School of Chinese Pharmacy, Beijing University of Chinese Medicine , Beijing , China.
Ying Liua School of Chinese Pharmacy, Beijing University of Chinese Medicine , Beijing , China.
Beijing University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextIncreasing incidence and impact of inflammatory diseases have encouraged the search of new pharmacological strategies to face them. Licorice has been used to treat inflammatory diseases since ancient times in China.

objectiveTo summarize the current knowledge on anti-inflammatory properties and mechanisms of compounds isolated from licorice, to introduce the traditional use, modern clinical trials and officially approved drugs, to evaluate the safety and to obtain new insights for further research of licorice.

methodsPubMed, Web of Science, Science Direct and ResearchGate were information sources for the search terms 'licorice', 'licorice metabolites', 'anti-inflammatory', 'triterpenoids', 'flavonoids' and their combinations, mainly from year 2010 to 2016 without language restriction. Studies were selected from Science Citation Index journals, in vitro studies with Jadad score less than 2 points and in vivo and clinical studies with experimental flaws were excluded.

resultsTwo hundred and ninety-five papers were searched and 93 papers were reviewed. Licorice extract, 3 triterpenes and 13 flavonoids exhibit evident anti-inflammatory properties mainly by decreasing TNF, MMPs, PGE2 and free radicals, which also explained its traditional applications in stimulating digestive system functions, eliminating phlegm, relieving coughing, nourishing qi and alleviating pain in TCM. Five hundred and fifty-four drugs containing licorice have been approved by CFDA. The side effect may due to the cortical hormone like action.

conclusionLicorice and its natural compounds have demonstrated anti-inflammatory activities. More pharmacokinetic studies using different models with different dosages should be carried out, and the maximum tolerated dose is also critical for clinical use of licorice extract and purified compounds.

Indexed as

AnimalsAnti-Inflammatory AgentsHumansInflammationInflammation MediatorsMaximum Tolerated DosePhytotherapyPlant ExtractsPlants, MedicinalRisk AssessmentAnti-Inflammatory AgentsInflammation MediatorsPlant Extractsflavonoidglycyrrhetinic acidGlycyrrhiza glabra L.Glycyrrhiza inflata Bat.Glycyrrhiza uralensis Fisch.glycyrrhizin

Identifiers

PMID27650551
PMCPMC7012004
OpenAlexW2521532521

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.